Please login to the form below

Not currently logged in
Email:
Password:

e-Therapeutics opens new UK drug discovery centre

Oxford facility will lead company's work in network pharmacology

Newcastle, UK-based e-Therapeutics has opened a new drug discovery facility in Long Hanborough, near Oxford.

The Network Pharmacology Centre will focus on searching for novel treatments for cancer and degenerative diseases of the nervous system.

The Centre was officially declared open by the Prime Minister, David Cameron.

He said: “e-Therapeutics is a fascinating and innovative business in my constituency. Their use of pioneering science has the potential to deliver great results and I very much hope that their treatments are successful.”

Professor Malcolm Young, founder and CEO of e-Therapeutics, said: “We are delighted to have the Prime Minister open our new drug discovery centre near Oxford, which is a world centre of excellence in the science that underpins our business.”

e-Therapeutics says its work in 'network pharmacology', which combines advances in chemical biology and network science, has the potential to produce new and improved treatments for complex diseases.

It involves applying network analysis to determine the set of proteins most critical in any disease, and then using chemical biology techniques to identify molecules capable of targeting that set of proteins.

During 2012 e-Therapeutics plans to advance four drugs derived from network pharmacology research into clinical trials.

These include potential treatments for cancer, major depressive disorder and resistant bacterial infections.

28th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics